Home > News > ACLARA Signs GlaxoSmithKline to eTag™ Access Agreement
July 30th, 2003
ACLARA Signs GlaxoSmithKline to eTag™ Access Agreement
Abstract:
ACLARA BioSciences announced today that it has entered into an eTag™ Access Agreement with GlaxoSmithKline (GSK), under which GSK will gain access to ACLARA's proprietary eTag Assay System for use in its biopharmaceutical research and development activities.
Source:
ACLARA
Bookmark:
| Related News Press |
Announcements
Rice membrane extracts lithium from brines with greater speed, less waste October 3rd, 2025
Researchers develop molecular qubits that communicate at telecom frequencies October 3rd, 2025
Next-generation quantum communication October 3rd, 2025
"Nanoreactor" cage uses visible light for catalytic and ultra-selective cross-cycloadditions October 3rd, 2025
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||